Contrast-enhanced mammography: past, present, and future

Sogani, Julie; Mango, Victoria L.; Keating, Delia M.; Sung, Janice S.; Jochelson, Maxine S.

doi:10.1016/j.clinimag.2020.09.003

Cited by 72 publications

(61 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our preliminary experience and according to current literature [ 21 , 27 ], CESM could accurately help diagnosis in different clinical settings, particularly in patients with MR-contraindications or physical limitations.…”

Section: Discussionmentioning

confidence: 84%

“…The transition from the prone to the supine position determines changes in the overall thickness of the breast and spatial depiction of the lesion; this displacement can be more or less important and can occur in the same quadrant or in different quadrants. However, small non-mass enhancement lesions at MR are difficult to perceive at ultrasound and the correlation between the MR findings and the ultrasound alterations is not always perfect [ 21 , 23 ].…”

Section: Discussionmentioning

confidence: 99%

“…Several studies demonstrated the good diagnostic performance of CESM in detecting breast cancer. CESM may be useful for indications previously reserved for MR, and its role in different clinical settings is being assessed [ 21 , 27 ].…”

Section: Discussionmentioning

confidence: 99%

“…Recently, CESM has shown potential to increase the diagnostic possibilities of mammography, suggesting its use in various diagnostic challenges [ 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

“…CESM is a special type of mammogram that uses a dual energy exposure in combination with intravenous contrast medium administration. For each mammogram projection, a pair of low- and high-energy images are acquired and the relative subtracted images are obtained [ 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer

Costantini

Montella

Fadda

et al. 2021

JPM

View full text Add to dashboard Cite

Axillary lymph node metastases of occult breast cancer (CUPAx) is an unusual condition that represents both a diagnostic and therapeutic challenge. The first steps in the diagnostic work-up of patients with CUPAx are the histological analysis of the lymph node metastasis and the execution of basic breast diagnostic imaging (mammography and ultrasound). In the case of occult breast cancer, breast Magnetic Resonance (MR) must be performed. Breast MR identifies a suspicious lesion in many patients and second-look ultrasound detects a corresponding ultrasound alteration in about half of cases, allowing the performance of a US-guided biopsy. In the case of an MR-only lesion, MR-guided biopsy is mandatory. We present a case of CUPAx in which contrast-enhanced spectral mammography (CESM) is used to help the detection of occult breast cancer and to guide stereotactic vacuum breast biopsy (VABB). CESM is a new breast imaging technique that is proving to have good performance in breast cancer detection and that is showing potential in the identification of occult breast cancer in a CUPAx setting. The use of an innovative and personalized breast imaging approach in breast cancer patients improves diagnostic possibilities and promises to become the focus in decision strategies.

show abstract

Section: Discussionmentioning

confidence: 84%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…Recently, CESM has shown potential to increase the diagnostic possibilities of mammography, suggesting its use in various diagnostic challenges [ 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer

Costantini

Montella

Fadda

et al. 2021

JPM

View full text Add to dashboard Cite

show abstract

Differential diagnosis of cardiac tumors: General consideration and echocardiographic approach

Pino

Moreo

Lestuzzi

2022

J of Clinical Ultrasound

View full text Add to dashboard Cite

Cardiac tumors may be primary (either benign or malignant) or secondary (malignant) and are first detected by echocardiography in most cases. The cardiologist often challenges their identification, the differential diagnosis and the best therapeutic approach. Malignant tumors have usually a poor prognosis, which may be significantly improved by appropriate and timely therapies. The echocardiographic aspects of benign and malignant cardiac tumors described in this article, along with a clinical evaluation may orient the differential diagnosis and aid in choosing the further steps useful to define the nature of the mass,

show abstract

Five decades of progress in surgical oncology: Breast

Downs-Canner

Cody

2022

Journal of Surgical Oncology

View full text Add to dashboard Cite

Surgery remains the single most effective treatment for breast cancer but coincident with a deeper understanding of tumor biology and advances in multidisciplinary care (encompassing breast imaging, systemic adjuvant therapy, radiotherapy, and genomics) continues to de-escalate, supported by strong level I data. We have moved from mastectomy to breast conservation, and from routine axillary dissection to sentinel lymph node biopsy to selective omission of axillary node staging altogether. We have further de-escalated through consensus over margin width in breast conservation, through improvements in neoadjuvant therapy, and by demonstrating no benefit for upfront surgery in patients with stage IV disease.For patients with ipsilateral breast tumor recurrence, reconservation surgery and reirradiation are promising. Cell cycle and immune checkpoint inhibitors, when added to conventional systemic therapy, have now moved beyond stage IV disease to phase III trials in the adjuvant and neoadjuvant settings, promising even further de-escalation of surgery. Finally, with genomic profiling we are moving away from the primacy of axillary node status for prognostication and into a new era allowing prediction of response to therapy.

show abstract

Contrast-enhanced mammography: past, present, and future

Cited by 72 publications

References 68 publications

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer

Differential diagnosis of cardiac tumors: General consideration and echocardiographic approach

Five decades of progress in surgical oncology: Breast

Contact Info

Product

Resources

About